Literature DB >> 7067594

X-recessive angiopathic opticopathy.

L A Bastiaensen, J J Vandoninck.   

Abstract

A familial optic atrophy with X-recessive heredity, distinct from Leber's optic atrophy (LOA), is described. The symptoms are: slight to moderate pallor of the papillomacular bundle at the disc possibly preceded by some hyperaemia of the disc, telangiectasia on the disc with normal retinal vessels, occurrence in the second decade of life, slow progression with often subclinical visual loss, a small relative central scotoma with an intact peripheral visual field, slight acquired tritanopia and deuteranopia, and vasomotor headaches. The disease may exhibit severe exacerbations with loss of vision to 1/60, provoked by vasoconstrictors and reacting favourably to vasodilators. This acute loss of vision is associated with ischaemia of the disc, a deep central scotoma with marked disturbance of colour vision in the form of an acquired deuteranopia, and sensoparalytic pupils. This is followed by increasing pallor of the disc, slow resolution of the central scotoma with a permanent reduction in the central light sensitivity, markedly disturbed Visual Evoked Potentials (VEP), acquired deuteranopia and normal ERG and EOG. In contrast to all hereditary opticopathies so far described, fluorescein angiography showed a disturbance of perfusion in the peripapillary choroid and the prelaminar part of the optic nerve. A similar disturbance of perfusion is described in anterior ischaemic optic neuropathy (AION) and low-tension glaucoma. To these acquired, non-hereditary recessive vascular opticopathies, which usually occur late in life, will have to be added the X-recessive vascular optic atrophy which we describe here, for which we propose the name: X-recessive angiopathic opticopathy. The differential diagnosis from some other hereditary, especially X-recessive, optic atrophies is discussed.

Entities:  

Mesh:

Year:  1982        PMID: 7067594     DOI: 10.1007/bf01675853

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  19 in total

Review 1.  LEBER'S DISEASE IN THE NETHERLANDS.

Authors:  A H VANSENUS
Journal:  Doc Ophthalmol       Date:  1963       Impact factor: 2.379

2.  Histologic studies of the vasculature of the anterior optic nerve.

Authors:  M F Lieberman; A E Maumenee; W R Green
Journal:  Am J Ophthalmol       Date:  1976-09       Impact factor: 5.258

3.  G-6-PD Worcester. A new variant, associated with X-linked optic atrophy.

Authors:  L M Snyder; T F Necheles; W J Reddy
Journal:  Am J Med       Date:  1970-07       Impact factor: 4.965

4.  [Leber's optic atrophy - an interdisciplinary study (author's transl)].

Authors:  A Müller-Jensen; W Bushart; J Steidinger; M Funk; K A Hellner
Journal:  Klin Monbl Augenheilkd       Date:  1978       Impact factor: 0.700

5.  Leber's optic neuropathy: clinical and visual evoked response studies in asymptomatic and symptomatic members of a 4-generation family.

Authors:  I R Livingstone; F L Mastaglia; J W Howe; G E Aherne
Journal:  Br J Ophthalmol       Date:  1980-10       Impact factor: 4.638

6.  [Leber's disease and nervous-system-degeneration syndromes].

Authors:  A Bronner; J P Gerhard; M Collard; S Malamet
Journal:  Rev Otoneuroophtalmol       Date:  1979 Jan-Feb

7.  The genetics of Leber's optic atrophy and its neurological sequelae.

Authors:  L N Went; G W Bruyn
Journal:  J Genet Hum       Date:  1966-12

8.  The early phase in Leber hereditary optic atrophy.

Authors:  E Nikoskelainen; R L Sogg; A R Rosenthal; T R Friberg; L J Dorfman
Journal:  Arch Ophthalmol       Date:  1977-06

9.  [The acute phase of leber's optic nerve atrophy (author's transl)].

Authors:  G y Gács; P Rácz; J Szilvássy
Journal:  Klin Monbl Augenheilkd       Date:  1975-09       Impact factor: 0.700

10.  Leber's optic neuropathy: a clinical and visual evoked potential study of affected and asymptomatic members of a six generation family.

Authors:  W M Carroll; F L Mastaglia
Journal:  Brain       Date:  1979-09       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.